首頁 › 肝癌（肝細胞癌） › 俄亥俄州 › Cleveland
Cleveland, OH 的 肝癌（肝細胞癌） 臨床試驗
18 項針對 肝癌（肝細胞癌） 的研究正在 Cleveland（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中歡迎健康志工
- Louis Stokes Cleveland VA Medical Center, Cleveland
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
招募中1 期
- Exelixis Clinical Site #10, Cleveland
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
招募中1/2 期
- University Hospitals Cleveland Medical Center, Cleveland
National Liver Cancer Screening Trial
招募中4 期
- The Cleveland Clinic, Cleveland
A Study Evaluating a New Radiation Treatment Workflow (NGDS)
招募中
- University Hospital Cleveland Medical Center, Cleveland
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
招募中觀察性研究
- Cleveland Clinic Foundation, Cleveland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
招募中3 期
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 距離 10 英里
- UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 距離 22 英里
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
招募中1 期
- University Hospitals Cleveland Medical Center, Cleveland
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
招募中觀察性研究
- Cleveland Clinic, Cleveland
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
招募中1 期
- Clinical Trial Site, Cleveland
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
招募中
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)
招募中2 期
- Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
招募中1/2 期
- Cleveland Clinic Lerner College of Medicine, Cleveland
HOPE Against Cancer Recurrence in HCC
招募中4 期
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Mayfield Heights · 距離 12 英里
The Dragon PLC Trial (DRAGON-PLC)
招募中
- Cleveland Clinic, Cleveland
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
招募中1/2 期
- Cleveland Clinic, Cleveland
其他城市的 肝癌（肝細胞癌） 試驗
- Houston, TX31 項研究
- New York City, NY24 項研究
- Dallas, TX19 項研究
- Los Angeles, CA19 項研究
- Boston, MA18 項研究
- Chicago, IL16 項研究
- Philadelphia, PA16 項研究
- Pittsburgh, PA15 項研究
- San Francisco, CA14 項研究
- Orange, CA14 項研究
- Jacksonville, FL14 項研究
- San Antonio, TX13 項研究
Cleveland 的其他研究
- 非小細胞肺癌43 項研究
- 癌症（所有類型）36 項研究
- 乳癌35 項研究
- 前列腺癌34 項研究
- 心臟衰竭33 項研究
- 卵巢癌30 項研究
- 轉移性癌症30 項研究
- 肺癌26 項研究
- 大腸直腸癌24 項研究
- 心血管疾病22 項研究
- 子宮內膜癌20 項研究
- 急性髓系白血病20 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。